Obesity is recognized as a condition impacting female fertility throughout the process of conception, including natural and assisted reproductive technologies. Excess body fat can interfere with the regulation of the hypothalamus, pituitary gland, and ovaries. It also affects insulin signaling, inflammatory processes, oocyte quality, embryo development, and the receptivity of the uterine lining.
Key Clinical Findings
The review examines the connections between obesity and infertility, decreased effectiveness of ART, implantation difficulties, miscarriage, and lower live birth rates. These relationships are influenced by individual reproductive and metabolic characteristics. Specific conditions such as polycystic ovary syndrome, advanced age, reduced ovarian reserves, recurrent implantation failure, and recurrent pregnancy loss are highlighted in the context of obesity’s impact. The review considers strategies for weight reduction before fertility treatment, including lifestyle changes, glucagon-like peptide-1 receptor agonists, tirzepatide, and bariatric surgery. These approaches are evaluated for their potential to improve reproductive outcomes, the possible delay in treatment, and considerations for safety during pregnancy.